Parnell Pharmaceuticals Holdings Ltd. announced the appointment of Peter A. Croden to its Board of Directors. The
appointment increases the Board to seven directors, and the number of independent directors to four. Mr. Croden will serve on the Company's Audit and Compensation Committees. Peter Croden has over 35 years of experience in the Animal Health, Biotech, Private Equity and Pharmaceutical industries. Mr. Croden previously held senior pharmaceutical executive positions with The Upjohn Company and Pharmacia & Upjohn Animal Health. As President of the Worldwide Business for Pharmacia & Upjohn Animal Health, Mr. Croden oversaw the fast growing company in the industry. Mr. Croden also previously held the position of President of Upjohn Canada, before which he resided and worked in Germany for 6 years as Regional Marketing
Manager for Europe.